These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22023206)

  • 41. Development and evaluation of a gastroretentive drug delivery system for the low-absorption-window drug celecoxib.
    Ali J; Tyagi P; Ahuja A; Baboota S; Hasan S
    PDA J Pharm Sci Technol; 2007; 61(2):88-96. PubMed ID: 17479716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.
    El Nabarawi MA; Teaima MH; Abd El-Monem RA; El Nabarawy NA; Gaber DA
    Drug Des Devel Ther; 2017; 11():1081-1093. PubMed ID: 28435220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and characterization of novel site specific hollow floating microspheres bearing 5-Fu for stomach targeting.
    Bhardwaj P; Chaurasia D; Singh R; Swarup A
    ScientificWorldJournal; 2014; 2014():705259. PubMed ID: 25383377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of design of experiments to optimizing novel gastroretentive drug delivery of simvastatin.
    Jagdale S; Kurhe P; Kuchekar B; Chabukswar A
    Curr Drug Deliv; 2013 Oct; 10(5):527-41. PubMed ID: 23607639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation of rosiglitazone maleate sustained-release floating microspheres for improved bioavailability.
    Hu LD; Xing QB; Shang C; Liu W; Liu C; Luo ZL; Xu HX
    Pharmazie; 2010 Jul; 65(7):477-80. PubMed ID: 20662314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formulation development and evaluation of gastroretentive floating beads with Brucea javanica oil using ionotropic gelation technology.
    Zhang Y; Zhang XT; Zhang Q; Wang B; Zhang T
    Chin J Nat Med; 2018 Apr; 16(4):293-301. PubMed ID: 29703329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formulation and evaluation of gastroretentive microballoons containing baclofen for a floating oral controlled drug delivery system.
    Dube TS; Ranpise NS; Ranade AN
    Curr Drug Deliv; 2014; 11(6):805-16. PubMed ID: 24730440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stomach-specific drug delivery of 5-fluorouracil using ethylcellulose floating microspheres.
    Vaghani S; Vasanti S; Chaturvedi K; Satish CS; Jivani NP
    Pharm Dev Technol; 2010; 15(2):154-61. PubMed ID: 20214502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Raft forming system-an upcoming approach of gastroretentive drug delivery system.
    Prajapati VD; Jani GK; Khutliwala TA; Zala BS
    J Control Release; 2013 Jun; 168(2):151-65. PubMed ID: 23500062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enteric-coated pellets: theoretical analysis of effect of dispersion in the stomach on blood level profiles.
    Story MJ
    J Pharm Sci; 1977 Oct; 66(10):1495-6. PubMed ID: 925915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a gastroretentive pulsatile drug delivery platform.
    Thitinan S; McConville JT
    J Pharm Pharmacol; 2012 Apr; 64(4):505-16. PubMed ID: 22420657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Gastroretentive dosage forms].
    Kiss D; Zelkó R
    Acta Pharm Hung; 2005; 75(3):169-76. PubMed ID: 16318241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastroretentive delivery systems: a mini review.
    Talukder R; Fassihi R
    Drug Dev Ind Pharm; 2004; 30(10):1019-28. PubMed ID: 15595568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Floating gastroretentive drug delivery systems: Comparison of experimental and simulated dissolution profiles and floatation behavior.
    Eberle VA; Schoelkopf J; Gane PA; Alles R; Huwyler J; Puchkov M
    Eur J Pharm Sci; 2014 Jul; 58():34-43. PubMed ID: 24704154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation and evaluation of a novel gastric mucoadhesive sustained-release acyclovir microsphere.
    Liu H; Pan W; Ke P; Dong Y; Ji L
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1098-105. PubMed ID: 20545521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
    Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
    Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and evaluation of a floating multiparticulate gastroretentive system for modified release of AZT.
    Yoshida VM; de Oliveira Junior JM; Gonçalves MM; Vila MM; Chaud MV
    AAPS PharmSciTech; 2011 Jun; 12(2):658-64. PubMed ID: 21562720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.
    Grimm M; Ball K; Scholz E; Schneider F; Sivert A; Benameur H; Kromrey ML; Kühn JP; Weitschies W
    Eur J Pharm Sci; 2019 Mar; 129():163-172. PubMed ID: 30639530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs.
    Klausner EA; Lavy E; Stepensky D; Friedman M; Hoffman A
    Pharm Res; 2002 Oct; 19(10):1516-23. PubMed ID: 12425470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.